The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient
![Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV - Applied DNA Sciences Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV - Applied DNA Sciences](https://adnas.com/wp-content/uploads/2020/02/coronavirus-candidate2.png)
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV - Applied DNA Sciences
![COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001621004664-gr1.jpg)
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect
![Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML](https://www.mdpi.com/pathogens/pathogens-10-00788/article_deploy/html/images/pathogens-10-00788-g003.png)
Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML
![Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models - Applied DNA Sciences Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models - Applied DNA Sciences](https://adnas.com/wp-content/uploads/2020/01/scientists-analyzing-data-scaled.jpg)
Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models - Applied DNA Sciences
![COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19 | bioRxiv COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19 | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/06/14/2021.06.14.448343/F1.large.jpg)
COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19 | bioRxiv
![Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed - Applied DNA Sciences Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed - Applied DNA Sciences](https://adnas.com/wp-content/uploads/2020/03/coronavirus-march.png)
Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed - Applied DNA Sciences
![COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001621004664-fx1.jpg)
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect
![Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML](https://www.mdpi.com/pathogens/pathogens-10-00788/article_deploy/html/images/pathogens-10-00788-g002.png)
Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML
![2 March 2020 - Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed 2 March 2020 - Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed](https://www.takisbiotech.it/images/news/AppliedDNA_LinearDNA_covid-19_Takis_Evvivax.jpg)
2 March 2020 - Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
![COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001621004664-gr3.jpg)